374 related articles for article (PubMed ID: 12738333)
1. Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.
Kim HK; Silver B; Li S; Neuberg D; Mauch P
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):556-60. PubMed ID: 12738333
[TBL] [Abstract][Full Text] [Related]
2. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
3. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
[TBL] [Abstract][Full Text] [Related]
4. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. Australasian Radiation Oncology Lymphoma Group.
Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Liew KH; Morgan G
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):227-36. PubMed ID: 7836074
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Khoo V; Liew KH; Morgan G; O'Brien P; Pendlebury S; Pratt G; Quong G; Roos DE; Thornton D; Trotter G; Walker Q; Wallington M
Radiother Oncol; 1996 Apr; 39(1):1-7. PubMed ID: 8735487
[TBL] [Abstract][Full Text] [Related]
8. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
Tate DJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
[TBL] [Abstract][Full Text] [Related]
9. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
10. Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease.
Backstrand KH; Ng AK; Takvorian RW; Jones EL; Fisher DC; Molnar-Griffin BJ; Silver B; Tarbell NJ; Mauch PM
J Clin Oncol; 2001 Feb; 19(3):736-41. PubMed ID: 11157025
[TBL] [Abstract][Full Text] [Related]
11. Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Hodgson DC; Tsang RW; Pintilie M; Sun A; Wells W; Crump M; Gospodarowicz MK
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1374-81. PubMed ID: 14630276
[TBL] [Abstract][Full Text] [Related]
12. Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
Press OW; LeBlanc M; Lichter AS; Grogan TM; Unger JM; Wasserman TH; Gaynor ER; Peterson BA; Miller TP; Fisher RI
J Clin Oncol; 2001 Nov; 19(22):4238-44. PubMed ID: 11709567
[TBL] [Abstract][Full Text] [Related]
13. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.
Hughes-Davies L; Tarbell NJ; Coleman CN; Silver B; Shulman LN; Linggood R; Canellos GP; Mauch PM
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):361-9. PubMed ID: 9308940
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201
[TBL] [Abstract][Full Text] [Related]
15. Is combined modality therapy necessary for advanced Hodgkin's disease?
Mendenhall NP; Bennett CJ; Lynch JW
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):583-92. PubMed ID: 9231683
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone.
Dühmke E; Diehl V; Loeffler M; Mueller RP; Ruehl U; Willich N; Georgii A; Roth S; Matthaei D; Sehlen S; Brosteanu O; Hasenclever D; Wilkowski R; Becker K
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):305-10. PubMed ID: 8892452
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
18. Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency.
Leslie NT; Mauch PM; Hellman S
Cancer; 1985 May; 55(9 Suppl):2072-8. PubMed ID: 3919921
[TBL] [Abstract][Full Text] [Related]
19. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
20. The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control.
Mendenhall NP; Rodrigue LL; Moore-Higgs GJ; Marcus RB; Million RR
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):551-61. PubMed ID: 10348284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
